Bifido Launches Health Functional Food Using Weissella Bacteria

[Asia Economy Reporter Hyunseok Yoo] Bifido announced on the 20th that it plans to develop and launch an individually recognized health functional food for constipation improvement using Weissella bacteria.

Bifido independently develops starter cultures to produce strains and finished products, which are sold domestically and internationally. Recently, it has attracted attention by discovering a human-derived strain effective for constipation improvement and filing a patent for it.

A company representative stated, "After isolating and analyzing various strains from stool samples of children and adults, we selected strains that produce EPS (Exopolysaccharide) effective for constipation improvement. As a result, Weissella bacteria were found to contain a large amount of EPS effective for constipation improvement, and based on this result, we filed a patent."

The EPS, a fermentation product of Weissella bacteria, has water retention capacity that is significantly superior compared to other bacteria. It has high viscoelasticity and solubility. It is not decomposed by human digestive enzymes and has been confirmed to aid bowel movements as a dietary fiber.

Based on the research results, Bifido plans to develop and launch a new individually recognized health functional food for constipation improvement using Weissella bacteria. In relation to this, the company recently purchased about 3,000 pyeong of land at the former Goryeo Furniture site in the Hongcheon Agricultural and Industrial Complex and plans to expand its factory to increase production capacity due to the new product launch and increased existing orders.

Meanwhile, Bifido is also conducting various research and development and launching products in industries such as therapeutics using microorganisms and cosmetics, in addition to the probiotics industry.

This content was produced with the assistance of AI translation services.